269 related articles for article (PubMed ID: 33577678)
1. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
[TBL] [Abstract][Full Text] [Related]
2. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
Vickers TA; Rahdar M; Prakash TP; Crooke ST
Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
4. NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.
Zhang L; Bernardo KD; Vickers TA; Tian J; Liang XH; Crooke ST
Nucleic Acid Ther; 2022 Aug; 32(4):280-299. PubMed ID: 35852833
[TBL] [Abstract][Full Text] [Related]
5. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.
Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP
Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
[TBL] [Abstract][Full Text] [Related]
7. Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.
Migawa MT; Shen W; Wan WB; Vasquez G; Oestergaard ME; Low A; De Hoyos CL; Gupta R; Murray S; Tanowitz M; Bell M; Nichols JG; Gaus H; Liang XH; Swayze EE; Crooke ST; Seth PP
Nucleic Acids Res; 2019 Jun; 47(11):5465-5479. PubMed ID: 31034558
[TBL] [Abstract][Full Text] [Related]
8. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
[TBL] [Abstract][Full Text] [Related]
9. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
[TBL] [Abstract][Full Text] [Related]
10. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
Liang XH; Sun H; Nichols JG; Crooke ST
Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
[TBL] [Abstract][Full Text] [Related]
12. Phosphorothioate modified oligonucleotide-protein interactions.
Crooke ST; Vickers TA; Liang XH
Nucleic Acids Res; 2020 Jun; 48(10):5235-5253. PubMed ID: 32356888
[TBL] [Abstract][Full Text] [Related]
13. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.
Liang XH; Shen W; Sun H; Prakash TP; Crooke ST
Nucleic Acids Res; 2014 Jul; 42(12):7819-32. PubMed ID: 24861627
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-
Zhang L; Liang XH; De Hoyos CL; Migawa M; Nichols JG; Freestone G; Tian J; Seth PP; Crooke ST
Nucleic Acid Ther; 2022 Oct; 32(5):401-411. PubMed ID: 35861704
[TBL] [Abstract][Full Text] [Related]
15. COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways.
Liang XH; Sun H; Nichols JG; Allen N; Wang S; Vickers TA; Shen W; Hsu CW; Crooke ST
Nucleic Acids Res; 2018 Nov; 46(19):10225-10245. PubMed ID: 30239896
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.
Bailey JK; Shen W; Liang XH; Crooke ST
Nucleic Acids Res; 2017 Oct; 45(18):10649-10671. PubMed ID: 28977508
[TBL] [Abstract][Full Text] [Related]
17. Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective.
Liang XH; De Hoyos CL; Shen W; Zhang L; Fazio M; Crooke ST
Nucleic Acid Ther; 2021 Apr; 31(2):126-144. PubMed ID: 33534636
[TBL] [Abstract][Full Text] [Related]
18. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
Vickers TA; Crooke ST
Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2016 Sep; 44(15):7314-30. PubMed ID: 27378781
[TBL] [Abstract][Full Text] [Related]
20. RNA modifications can affect RNase H1-mediated PS-ASO activity.
Doxtader Lacy KA; Liang XH; Zhang L; Crooke ST
Mol Ther Nucleic Acids; 2022 Jun; 28():814-828. PubMed ID: 35664704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
